Another study revealed the clinical usage of MALAT1 in diagnosing PCa with AUC = 0.670 for patients with PSA 4 ng/ml and AUC = 0.742 for patients with PSA 10 ng/ml. Here, MALAT1 is linked to posterior cortical atrophy.